141 related articles for article (PubMed ID: 2199033)
1. Formation and persistence of novel benzo(a)pyrene adducts in rat lung, liver, and peripheral blood lymphocyte DNA.
Ross J; Nelson G; Kligerman A; Erexson G; Bryant M; Earley K; Gupta R; Nesnow S
Cancer Res; 1990 Aug; 50(16):5088-94. PubMed ID: 2199033
[TBL] [Abstract][Full Text] [Related]
2. Persistence of benzo(a)pyrene metabolite:DNA adducts in lung and liver of mice.
Kulkarni MS; Anderson MW
Cancer Res; 1984 Jan; 44(1):97-101. PubMed ID: 6317174
[TBL] [Abstract][Full Text] [Related]
3. Adenomas induced by polycyclic aromatic hydrocarbons in strain A/J mouse lung correlate with time-integrated DNA adduct levels.
Ross JA; Nelson GB; Wilson KH; Rabinowitz JR; Galati A; Stoner GD; Nesnow S; Mass MJ
Cancer Res; 1995 Mar; 55(5):1039-44. PubMed ID: 7866986
[TBL] [Abstract][Full Text] [Related]
4. Rat and human explant metabolism, binding studies, and DNA adduct analysis of benzo(a)pyrene and its 6-nitro derivative.
Garner RC; Stanton CA; Martin CN; Harris CC; Grafstrom RC
Cancer Res; 1985 Dec; 45(12 Pt 1):6225-31. PubMed ID: 4063973
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent benzo(a)pyrene [B(a)P]-DNA adduct levels and persistence in F-344 rats following subchronic dietary exposure to B(a)P.
Ramesh A; Knuckles ME
Cancer Lett; 2006 Aug; 240(2):268-78. PubMed ID: 16288829
[TBL] [Abstract][Full Text] [Related]
6. Relationships among benzo(a)pyrene metabolism, benzo(a)pyrene-diol-epoxide:DNA adduct formation, and sister chromatid exchanges in human lymphocytes from smokers and nonsmokers.
Thompson CL; McCoy Z; Lambert JM; Andries MJ; Lucier GW
Cancer Res; 1989 Dec; 49(23):6503-11. PubMed ID: 2510927
[TBL] [Abstract][Full Text] [Related]
7. Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts.
Balu N; Padgett WT; Nelson GB; Lambert GR; Ross JA; Nesnow S
Anal Biochem; 2006 Aug; 355(2):213-23. PubMed ID: 16797471
[TBL] [Abstract][Full Text] [Related]
8. Effect of butylated hydroxyanisole, alpha-angelica lactone, and beta-naphthoflavone on benzo(alpha)pyrene:DNA adduct formation in vivo in the forestomach, lung, and liver of mice.
Ioannou YM; Wilson AG; Anderson MW
Cancer Res; 1982 Apr; 42(4):1199-204. PubMed ID: 7059996
[TBL] [Abstract][Full Text] [Related]
9. DNA adducts in rat lung, liver and peripheral blood lymphocytes produced by i.p. administration of benzo[a]pyrene metabolites and derivatives.
Ross J; Nelson G; Erexson G; Kligerman A; Earley K; Gupta RC; Nesnow S
Carcinogenesis; 1991 Oct; 12(10):1953-5. PubMed ID: 1934277
[TBL] [Abstract][Full Text] [Related]
10. Exposure-route-dependent DNA adduct formation by polycyclic aromatic hydrocarbons.
Godschalk RW; Moonen EJ; Schilderman PA; Broekmans WM; Kleinjans JC; Van Schooten FJ
Carcinogenesis; 2000 Jan; 21(1):87-92. PubMed ID: 10607738
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen-DNA adduct formation in rat liver determined by immunoassay and 32P-postlabeling.
Divi RL; Osborne MR; Hewer A; Phillips DH; Poirier MC
Cancer Res; 1999 Oct; 59(19):4829-33. PubMed ID: 10519392
[TBL] [Abstract][Full Text] [Related]
12. Dose-response relationships for the binding of benzo(a)pyrene metabolites to DNA and protein in lung, liver, and forestomach of control and butylated hydroxyanisole-treated mice.
Adriaenssens PI; White CM; Anderson MW
Cancer Res; 1983 Aug; 43(8):3712-9. PubMed ID: 6305492
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of a novel benzo[a]pyrene-derived DNA adduct.
Fang AH; Smith WA; Vouros P; Gupta RC
Biochem Biophys Res Commun; 2001 Feb; 281(2):383-9. PubMed ID: 11181059
[TBL] [Abstract][Full Text] [Related]
14. Inhibition in vivo of the formation of adducts between metabolites of benzo(a)pyrene and DNA by butylated hydroxyanisole.
Anderson MW; Boroujerdi M; Wilson AG
Cancer Res; 1981 Nov; 41(11 Pt 1):4309-15. PubMed ID: 6272975
[TBL] [Abstract][Full Text] [Related]
15. DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay.
Gyorffy E; Anna L; Gyori Z; Segesdi J; Minárovits J; Soltész I; Kostic S; Csekeo A; Poirier MC; Schoket B
Carcinogenesis; 2004 Jul; 25(7):1201-9. PubMed ID: 15001535
[TBL] [Abstract][Full Text] [Related]
16. Treatment of lacZ plasmid-based transgenic mice with benzo[a]pyrene: measurement of DNA adduct levels, mutant frequencies, and mutant spectra.
Boerrigter ME
Environ Mol Mutagen; 1999; 34(2-3):140-7. PubMed ID: 10529738
[TBL] [Abstract][Full Text] [Related]
17. Species- and length of exposure-dependent differences in the benzo(a)pyrene:DNA adducts formed in embryo cell cultures from mice, rats, and hamsters.
Sebti SM; Pruess-Schwartz D; Baird WM
Cancer Res; 1985 Apr; 45(4):1594-600. PubMed ID: 3978626
[TBL] [Abstract][Full Text] [Related]
18. Influences of DNA isolation and RNA contamination on carcinogen-DNA adduct analysis by 32P-postlabeling.
Godschalk RW; Maas LM; Kleinjans JC; Van Schooten FJ
Environ Mol Mutagen; 1998; 32(4):344-50. PubMed ID: 9882009
[TBL] [Abstract][Full Text] [Related]
19. Interspecies differences in the major DNA adducts formed from benzo(a)pyrene but not 7,12-dimethylbenz(a)anthracene in rat and human mammary cell cultures.
Moore CJ; Pruess-Schwartz D; Mauthe RJ; Gould MN; Baird WM
Cancer Res; 1987 Aug; 47(16):4402-6. PubMed ID: 3111685
[TBL] [Abstract][Full Text] [Related]
20. DNA adduct formation and T lymphocyte mutation induction in F344 rats implanted with tumorigenic doses of 1,6-dinitropyrene.
Beland FA
Res Rep Health Eff Inst; 1995 Oct; (72):1-27; discussion 29-39. PubMed ID: 11381742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
